Cargando…
The Role of BRAF Inhibitors in the Management of Ameloblastoma: A Literature Review
Ameloblastoma is one of the most prevalent but enigmatic benign odontogenic tumors of the jaw, accounting for approximately 10% of all maxillary and mandibular tumors. This neoplasia is distinguished by exhibiting several clinical and histological variants along with several mutations that affect it...
Autores principales: | Malakar, Arindam, Kumar, V. Raj, Yadav, Priya, Bhardwaj, Vishal, Barua, Chuimee Gogoi, Bhardwaj, Gourika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673693/ https://www.ncbi.nlm.nih.gov/pubmed/38021761 http://dx.doi.org/10.7759/cureus.47682 |
Ejemplares similares
-
The Role of 5-Fluorouracil in Preventing Recurrence After Enucleation of Odontogenic Keratocyst: A Case Report
por: Barua, Chuimee Gogoi, et al.
Publicado: (2023) -
BRAF inhibitors in BRAF V600E-mutated ameloblastoma: systematic review of rare cases in the literature
por: Ebeling, Marcel, et al.
Publicado: (2023) -
BRAF inhibitor: a novel therapy for ameloblastoma in mandible
por: Abe, Masanobu, et al.
Publicado: (2018) -
Surgical management of ameloblastoma. Review of literature
por: Neagu, David, et al.
Publicado: (2019) -
High frequency of BRAF V600E mutations in ameloblastoma
por: Kurppa, Kari J, et al.
Publicado: (2014)